Form 4: Cardlytics Director Jonathan Edward Francis Acquires 11,000 Restricted Stock Units

Director Jonathan Edward Francis acquired 11,000 restricted stock units in Cardlytics, Inc. on May 23, 2024.

Summary

• On May 23, 2024, Jonathan Edward Francis, a director of Cardlytics, Inc., acquired 11,000 restricted stock units (RSUs).
• Each RSU represents a contingent right to receive one share of Cardlytics common stock or its cash equivalent, at the issuer's election.
• The RSUs will vest in full on the one-year anniversary of the grant date, provided Francis remains a director at that time.
• Following the transaction, Francis directly owns 11,000 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it is a standard disclosure of stock unit acquisition. The vesting conditions suggest a positive outlook for the company's performance.

Positives

• The acquisition of RSUs by a director signals confidence in the company's future performance.

Future Outlook

The vesting of the RSUs is contingent on the director's continued service, aligning his interests with the company's long-term success.

Industry Context

Form 4 filings are routine disclosures of transactions by company insiders and are used to monitor ownership changes and potential insider trading.

Stakeholder Impact

• The acquisition of RSUs by a director can positively influence shareholder confidence.

Key Dates